Abeona Therapeutics Inc vs ProShares Ultra Bloomberg Natural Gas ETF — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while ProShares Ultra Bloomberg Natural Gas ETF trades at $20.89. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, ProShares Ultra Bloomberg Natural Gas ETF nearer its low. Which is the better fit depends on your goals.
| ABEO | BOIL | |
|---|---|---|
Market Cap | $421.19M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $7.45 | $87.24 |
52-Week Low | $4.17 | $18.74 |
Enterprise Value | $276.10M | — |
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →BOIL is a leveraged ETF that seeks to provide two times (2x) the daily performance of the Bloomberg Natural Gas Subindex. It uses futures contracts to offer magnified exposure to natural gas price movements.
Read more on BOIL →